Toward Therapy of Human Prion Diseases (original) (raw)

  1. Home
  2. A-Z Publications
  3. Annual Review of Pharmacology and Toxicology
  4. Volume 58, 2018
  5. Article

Abstract

Three decades after the discovery of prions as the cause of Creutzfeldt-Jakob disease and other transmissible spongiform encephalopathies, we are still nowhere close to finding an effective therapy. Numerous pharmacological interventions have attempted to target various stages of disease progression, yet none has significantly ameliorated the course of disease. We still lack a mechanistic understanding of how the prions damage the brain, and this situation results in a dearth of validated pharmacological targets. In this review, we discuss the attempts to interfere with the replication of prions and to enhance their clearance. We also trace some of the possibilities to identify novel targets that may arise with increasing insights into prion biology.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-pharmtox-010617-052745

2018-01-06

2024-11-14

Loading full text...

Full text loading...

/deliver/fulltext/pharmtox/58/1/annurev-pharmtox-010617-052745.html?itemId=/content/journals/10.1146/annurev-pharmtox-010617-052745&mimeType=html&fmt=ahah

Most Read This Month

Article

content/journals/pharmtox

Journal

5

3

false

en

Loading